Eurospine Meeting in Dublin

Recently we were together with 3600 other doctors at the Eurospine Meeting in Dublin. Here it became clear again that combating postsurgical pain is becoming an increasingly important place on the agenda. Sessions on this topic were well attended and lively discussions arose.

Much attention was paid to the positive effects of so-called rapid recovery / early mobilization programs. This is urgently needed. While modern medical procedures are becoming more and more successful there is still much to do in the recovery after surgery. Many patients experience the postoperative period as painful and find recovery to be slow and riddled with complications and all types of setbacks. 

Being confined to bed has been shown to greatly increase the risk for various serious conditions including chest infections, urinary infections, thrombo-embolic events, obstipation, and skin ulcers. Getting surgical patients out of bed and into early mobilization programs as soon as the pain allows is expected to get renewed focus and attention from caregivers as they prepare for a generation of patients used to their independence and previous high levels of activity. Being able to control the pain perceived by surgical patients is suggested to be key in the successful implementations of these ‘rapid recovery’-type programs.

 The next newsletter will discuss the most painful surgical interventions, and what important role orthopedic surgery plays in this.

Leave a Reply

Newsletter SentryX

Receive updates about the developments on our innovative solution to relieve postsurgical pain.

Dr. Vaccaro has served as the president of the Rothman Orthopaedic Institute since 2014, and is the Richard H. Rothman Professor and Chairman in the Department of Orthopaedic Surgery, and Professor of Neurosurgery at Thomas Jefferson University in Philadelphia, Pennsylvania.

He is the President-elect of Cervical Spine Research Society (CSRS), 2019. He was the recipient of the Leon Wiltse award given for excellence in leadership and clinical research for spine care by the North American Spine Society (NASS) and is the past President of the American Spinal Injury Association and the Association for Collaborative Spine Research.

He has over 730 peer reviewed and 200 non-peer reviewed publications.  He has published over 346 book chapters and is the editor of over 55 textbooks and co-editor of OKU-Spine I and editor of OKU-8.  Dr. Vaccaro also serves as Co-Director of the Regional Spinal Cord Injury Center of the Delaware Valley and  Co-Director of Spine Surgery and the Spine Fellowship program at Thomas Jefferson University Hospital, where he instructs current fellows and residents in the diagnosis and treatment of various spinal problems and disorders.

 

Raymond Schiffelers is professor of Nano Medicine at the faculty Clinical Chemistry and Hematology at the UMC Utrecht. He is specialized in drug delivery and drug targeting. Currently he coordinates the H2020 B-Smart program and participates in several EU and national projects on nano-medicine.

 

Professor Jos Malda is Head of Research at the Department of Orthopaedics, University Medical Center Utrecht and the Department of Equine Sciences, University of Utrecht. He also leads the Utrecht Biofabrication Facility. He is a long-standing Board member of the International Cartilage Repair Society and President of the International Society for Biofabrication.

 

Marianna Tryfonidou is professor of the Orthopaedics section of the department of Clinical Sciences of Companion Animals.

She is a specialist veterinary surgeon for companion animals and researcher into tissue regeneration. She coordinates theiPSpineproject that was recently awarded €15 million under the Horizon 2020 programme, towards researching a solution for chronic lower back pain.

 

Bas Oosterman is co-founder and CEO of SentryX.

Before he served as Chief Operating Officer of Julius Clinical and worked for Philips Electronics in various positions. He studied econometrics, received his PhD degree in Management and Organization, and is a (six sigma) Black Belt. His PhD thesis dealt with speeding up the time-to-market of new product innovation projects.

 

Jorrit-Jan Verlaan is co-founder and CTO/CMO of SentryX.

Sinds 2010 is dr. Verlaan werkzaam als orthopedisch chirurg in het UMC Utrecht. In hetzelfde centrum is hij (cum laude) gepromoveerd en opgeleid. Afwijkingen van de wervelkolom op basis van ongevallen, stofwisselingsziekten en, voornamelijk, oncologische aandoeningen behoren tot zijn terrein. Dr. Verlaan is actief in basale en toegepaste wetenschap en begeleidt meerdere PhD-studenten. Hij is (co-)auteur van meer dan 75 internationale peer-reviewed artikelen en vijftien hoofdstukken in internationale vakboeken. In de functie van opleider draagt hij zorg voor de ontwikkeling van assistenten in opleiding tot orthopedisch chirurg.